Key facts
- It has raised $12.2M across 1 recorded rounds; the latest was Seed Round ($4.2M) in Jun 2023.
- Notable investors include MedTech Innovator, Matter (Consulting Services (B2B)), Virginia Venture Partners, Sands Capital, JHH vc — 16 tracked in total.
- Luminoah has filed 1 Form D with the SEC, most recently Jun 2023 ($4.2M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Luminoah
Funding rounds
1 roundsAbout Luminoah
Developer of a closed-loop, data-enabled enteral nutrition platform designed to personalize and modernize nutrition therapy for patients with chronic conditions. The company offers a compact, wearable pump, smart nutrition consumables, a patient-facing mobile app and a provider intelligence platform, enabling patients and healthcare providers to monitor progress in real time and improve adherence across home and clinical environments.
- Sector
- Healthcare
- HQ
- Charlottesville, VA, United States
- Founded
- 2020
- Employees
- 10
- Website
- luminoah.com/
- Ownership
- Privately Held (backing)
Luminoah doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Luminoah shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Luminoah in its N-PORT filings yet. We sweep new filings monthly.